13th Invest in ME Research International ME Conference - 1st June 2018

Andy

Andy

Retired committee member
Putting this up early so currently not much detail yet. Don't forget Early Bird pricing is available until 3rd March 2018.
This annual international, CPD accredited research conference provides a platform for the latest and most promising biomedical research into ME.
IIMEC13 will be the thirteenth conference and regularly attracts researchers, clinicians, doctors, nurses, occupational therapists, healthcare professionals and patient groups twenty countries from around the world.

The conference is a full day event from 09.00 to 17.30.
Click to expand...
http://www.investinme.eu/IIMEC13.shtml
 
Every year I hope to go to this but nearer the time it becomes clear I'm not well enough to attempt it. Here's hoping 2018 will be different. Always a lot of very interesting stuff to come out of the conference.
 
Finland's Professor Hyöty has been added
We are pleased to announce that Professor Hyöty has accepted.

A research group at the University of Tampere led by Professor Hyöty has long pioneered the development of a vaccine that could prevent Type 1 Diabetes.

Professor Hyöty has been leading several large scale international projects relating to research into diabetes.

This research has been able to identify the enteroviruses belonging to the group B coxsackieviruses that are related to diabetes. A prototype vaccine has been developed to prevent these viruses.

This may have implications for ME - at least it is of interest as a sub-group of ME patients may have become ill due to enteroviruses.
Click to expand...
http://www.investinme.eu/IIMEC13-news-180103.shtml
 
Sunshine3 said:
That is so lovely that Anne will be remembered.
Click to expand...
The speaker for the Anne Örtegren Memorial Lecture has been announced today: http://www.investinme.eu/IIMEC13-news-180202.shtml

To give the first Anne Örtegren Memorial Lecture we are very pleased to announce that Professor Theoharis C. Theoharides, Professor of Pharmacology and Internal Medicine at the Director of Molecular Immunopharmacology and Drug Discovery, Department of Immunology at Tufts University School of Medicine, Boston in USA. Read more: http://www.investinme.eu/IIMEC13-news-180202.shtml
Click to expand...
 
New speaker for 2018: http://www.investinme.eu/IIMEC13-news-180206.shtml

"Invest in ME Research is pleased to welcome Dr Peter Holger Johnsen from the University Hospital of North Norway, Harstad, Norway to participate in the IIMEC13 conference.

Last year the team at Harstad was awarded funding for a double blinded controlled randomised trial with 78 ME patients and investigating the use of faecal transplants for ME.

Dr Johnsen will also be participating in the BRMEC8 - the 8th Biomedical Research into ME colloquium."
 
Last edited:
You must log in or register to reply here.
Back
Top Bottom